BIAFW vs DHR · rev $6.2M vs P/E 39, rev $6.26B
bioAffinity Technologies Inc. Warrant (BIAFW) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
bioAffinity Technologies Inc. Warrant (BIAFW) common stock listed on US.
Danaher Corporation (DHR) is a diagnostics & research company listed on US. It is led by Rainer M. Blair.
Latest reported BIAFW revenue for 2025-12-31 was $6.2M. Net income was -$14.9M. Revenue was down 34.2% from 2024-12-31 to 2025-12-31. BIAFW currently screens at market cap $0.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
BIAFW currently screens at market cap $0. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the BIAFW and DHR stock pages for the full models.
Not investment advice.